Venous thromboembolism in plastic surgery: the current state of evidence in risk assessment and chemoprophylactic options

References

• Pannucci CJ, Bailey SH, Dreszer G, et al. Validation of the Caprini risk assessment model in plastic and reconstructive surgery patients. J Am Coll Surg. 2011;212:105–112.
   Google Scholar
• Keyes GR, Singer R, Iverson RE, et al. Incidence and predictors of venous thromboembolism in abdominoplasty. Aesthet Surg J. 2018;38:162–173.
   Google Scholar
• Winocour J, Gupta V, Kaoutzanis C, et al. venous thromboembolism in the cosmetic patient: analysis of 129,007 patients. Aesthet Surg J. 2017;37:337–349.
   Google Scholar
• Campbell W, Pierson J, Cohen-Shohet R, et al. Maximizing chemoprophylaxis against venous thromboembolism in abdominoplasty patients with the use of preoperative heparin administration. Ann Plast Surg. 2014;72:S94–S96.
   Google Scholar
• Hatef DA, Kenkel JM, Nguyen MQ, et al. Thromboembolic risk assessment and the efficacy of enoxaparin prophylaxis in excisional body contouring surgery. Plast Reconstr Surg. 2008;122:269–279.
   Google Scholar
• Pannucci CJ. Venous thromboembolism in aesthetic surgery: risk optimization in the preoperative, intraoperative, and postoperative settings. Aesthet Surg J. 2019;39:209–219.
   Google Scholar
• Trevidic P. [National survey of the deep vein thrombosis in plastic and aesthetic surgery, consequences and guidelines]. Ann Chir Plast Esthet. 2006;51:163–169.
   Google Scholar
• Spring MA, Gutowski KA. Venous thromboembolism in plastic surgery patients: survey results of plastic surgeons. Aesthet Surg J. 2006;26:522–529.
   Google Scholar
• Clavijo-Alvarez JA, Pannucci CJ, Oppenheimer AJ, et al. Prevention of venous thromboembolism in body contouring surgery: a national survey of 596 ASPS surgeons. Ann Plast Surg. 2011;66:228–232.
   Google Scholar
• Swanson E. Caprini scores, risk stratification, and rivaroxaban in plastic surgery: time to reconsider our strategy. Plast Reconstr Sur Glob Open. 2016;4:e733.
   Google Scholar
• Caprini JA, Arcelus JI, Hasty JH, et al. Clinical assessment of venous thromboembolic risk in surgical patients. Semin Thromb Hemost. 1991;17: 304–312.
   Google Scholar
• Venturi ML, Davison SP, Caprini JA. Prevention of venous thromboembolism in the plastic surgery patient: current guidelines and recommendations. Aesthet Surg J. 2009;29:421–428.
   Google Scholar
• Seruya M, Venturi ML, Iorio ML, et al. Efficacy and safety of venous thromboembolism prophylaxis in highest risk plastic surgery patients. Plast Reconstr Surg. 2008;122:1701–1708.
   Google Scholar
• Pannucci CJ, Dreszer G, Wachtman CF, et al. Postoperative enoxaparin prevents symptomatic venous thromboembolism in high-risk plastic surgery patients. Plast Reconstr Surg. 2011;128:1093–1103.
   Google Scholar
• Murphy RX, Schmitz D, Rosolowski K. Evidence-based practices for thromboembolism prevention: a report from the ASPS venous thromboembolism task force. 2011. [cited 2018 July 30]. Available from: https://www.plasticsurgery.org/documents/medical-professionals/health-policy/key-issues/ASPS_VTE_Report.pdf
   Google Scholar
• Pannucci CJ, Swistun L, MacDonald JK, et al. Individualized venous thromboembolism risk stratification using the 2005 Caprini score to identify the benefits and harms of chemoprophylaxis in surgical patients: a metaanalysis. Ann Surg. 2017;265:1094–1103.
   Google Scholar
• Pannucci CJ, Barta RJ, Portschy PR, et al. Assessment of postoperative venous thromboembolism risk in plastic surgery patients using the 2005 and 2010 Caprini Risk score. Plast Reconstr Surg. 2012;130:343–353.
   Google Scholar
• Pannucci CJ. Evidence-based recipes for venous thromboembolism prophylaxis: a practical safety guide. Plast Reconstr Surg. 2017;139:520e–532e.
   Google Scholar
• Collins R, Scrimgeour A, Yusuf S, et al. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med. 1988;318:1162–1173.
   Google Scholar
• Clagett GP, Reisch JS. Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis. Ann Surg. 1988;208:227–240.
   Google Scholar
• Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest. 2004;126:338S–400S.
   Google Scholar
• Prevention of fatal postoperative pulmonary embolism by low doses of heparin. An international multicentre trial. Lancet. 1975;2:45–51.
   Google Scholar
• Sagar S, Massey J, Sanderson JM. Low-dose heparin prophylaxis against fatal pulmonary embolism. Br Med J. 1975;4:257–259.
   Google Scholar
• Pezzuoli G, Neri Serneri GG, Settembrini P, et al. Prophylaxis of fatal pulmonary embolism in general surgery using low-molecular weight heparin Cy 216: a multicentre, double-blind, randomized, controlled, clinical trial versus placebo (STEP). STEP-Study Group. Int Surg. 1989;74:205–210.
   Google Scholar
• Wolf H, Encke A, Haas S, et al. Comparison of the efficacy and safety of Sandoz low molecular weight heparin and unfractionated heparin: interim analysis of a multicenter trial. Semin Thromb Hemost.. 1991;17:343–346.
   Google Scholar
• Mismetti P, Laporte S, Darmon JY, et al. Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg. 2001;88:913–930.
   Google Scholar
• Comparison of a low molecular weight heparin and unfractionated heparin for the prevention of deep vein thrombosis in patients undergoing abdominal surgery. The European Fraxiparin Study (EFS) Group. Br J Surg. 1988;75:1058–1063.
   Google Scholar
• Pannucci CJ, MacDonald JK, Ariyan S, et al. Benefits and risks of prophylaxis for deep venous thrombosis and pulmonary embolus in plastic surgery: a systematic review and meta-analysis of controlled trials and consensus conference. Plast Reconstr Surg. 2016;137:709–730.
   Google Scholar
• Pannucci CJ, Wachtman CF, Dreszer G, et al. The effect of postoperative enoxaparin on risk for reoperative hematoma. Plast Reconstr Surg. 2012;129:160–168.
   Google Scholar
• Caprini JA. Thrombosis risk assessment as a guide to quality patient care. Dis Mon.. 2005;51:70–78.
   Google Scholar
• Subichin MP, Patel NV, Wagner DS. Method of breast reconstruction determines venous thromboembolism risk better than current prediction models. Plast Reconstr Surg Glob Open. 2015;3:e397.
   Google Scholar
• Kim JY, Khavanin N, Rambachan A, et al. Surgical duration and risk of venous thromboembolism. JAMA Surg.. 2015;150:110–117.
   Google Scholar
• Moubayed SP, Eskander A, Mourad MW, et al. Systematic review and meta-analysis of venous thromboembolism in otolaryngologyhead and neck surgery. Head Neck. 2017;39:1249–1258.
   Google Scholar
• Bahl V, Shuman AG, Hu HM, et al. Chemoprophylaxis for venous thromboembolism in otolaryngology. JAMA Otolaryngol Head Neck Surg. 2014;140:999–1005.
   Google Scholar
• Swanson E. The case against chemoprophylaxis for venous thromboembolism prevention and the rationale for SAFE anesthesia. Plast Reconstr Surg Glob Open. 2014;2:e160.
   Google Scholar
• Swanson E. Venous thromboembolism risk stratification and chemoprophylaxis: a meta-analysis finds no benefit, more risk. Plast Reconstr Surg Glob Open. 2017;5:e1356.
   Google Scholar
• Bucknor A, Egeler SA, Chen AD, et al. National mortality rates after outpatient cosmetic surgery and low rates of perioperative deep vein thrombosis screening and prophylaxis. Plast Reconstr Surg. 2018;142:90–98.
   Google Scholar
• Pannucci CJ, Rockwell WB, Ghanem M, et al. Inadequate enoxaparin dosing predicts 90-day venous thromboembolism risk among plastic surgery inpatients: an examination of enoxaparin pharmacodynamics. Plast Reconstr Surg. 2017;139:1009–1020.
   Google Scholar
• Luce EA, Swanson E. Discussion: the impact of once- versus twice-daily enoxaparin prophylaxis on risk for venous thromboembolism and clinically relevant bleeding. Plast Reconstr Surg. 2018;142:250–251.
   Google Scholar
• Wei MY, Ward SM. The anti-factor Xa range for low molecular weight heparin thromboprophylaxis. Hematol Rep. 2015;7:5844.
   Google Scholar
• Cook K, Napolitano M, Padberg FT. Jr. Anti-factor Xa assay-A changing standard for venous thromboprophylaxis?. JAMA Surg.. 2016;151:1014.
   Google Scholar
• Pannucci CJ, Fleming KI, Agarwal J, et al. The impact of once- versus twice-daily enoxaparin prophylaxis on risk for venous thromboembolism and clinically relevant bleeding. Plast Reconstr Surg. 2018;142:239–249.
   Google Scholar
• Pannucci CJ, Fleming KI, Momeni A, et al. Twice-daily enoxaparin among plastic surgery inpatients: an examination of pharmacodynamics, 90-day venous thromboembolism, and 90-day bleeding. Plast Reconstr Surg. 2018;141:1580–1590.
   Google Scholar
• Sweetland S, Green J, Liu B, et al. Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study. BMJ. 2009;339:b4583.
   Google Scholar
• Harris WH, Salzman EW, Athanasoulis CA, et al. Aspirin prophylaxis of venous thromboembolism after total hip replacement. N Engl J Med. 1977;297:1246–1249.
   Google Scholar
• [No authors listed]. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet. 2000;355:1295–1302.
   Google Scholar
• Johanson NA, Lachiewicz PF, Lieberman JR, et al. Prevention of symptomatic pulmonary embolism in patients undergoing total hip or knee arthroplasty. J Am Acad Orthop Surg. 2009;17:183–196.
   Google Scholar
• Gent M, Hirsh J, Ginsberg JS, et al. Low-molecular-weight heparinoid orgaran is more effective than aspirin in the prevention of venous thromboembolism after surgery for hip fracture. Circulation. 1996;93:80–84.
   Google Scholar
• Graor R, Lotke PA, Davidson BL. RD heparin (ardeparin sodium) vs. aspirin to prevent deep venous thrombosis after hip or knee replacement surgery (abstract). Chest. 1992;102:118S.
   Google Scholar
• Becattini C, Agnelli G. Aspirin for prevention and treatment of venous thromboembolism. Blood Rev. 2014;28:103–108.
   Google Scholar
• Shah SS, Satin AM, Mullen JR, et al. Impact of recent guideline changes on aspirin prescribing after knee arthroplasty. J Orthop Surg Res. 2016;11:123.
   Google Scholar
• Bozic KJ, Vail TP, Pekow PS, et al. Does aspirin have a role in venous thromboembolism prophylaxis in total knee arthroplasty patients?. J Arthroplasty. 2010;25:1053–1060.
   Google Scholar
• Anderson DR, Dunbar MJ, Bohm ER, et al. Aspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trial. Ann Intern Med. 2013;158:800–806.
   Google Scholar
• Anderson DR, Dunbar M, Murnaghan J, et al. Aspirin or rivaroxaban for VTE prophylaxis after hip or knee arthroplasty. N Engl J Med. 2018;378:699–707.
   Google Scholar
• Parvizi J, Huang R, Restrepo C, et al. Low-dose aspirin is effective chemoprophylaxis against clinically important venous thromboembolism following total joint arthroplasty: a preliminary analysis. J Bone Joint Surg Am. 2017;99:91–98.
   Google Scholar
• Ashjian P, Chen CM, Pusic A, et al. The effect of postoperative anticoagulation on microvascular thrombosis. Ann Plast Surg. 2007;59:36– 40.
   Google Scholar
• Davison SP, Venturi ML, Attinger CE, et al. Prevention of venous thromboembolism in the plastic surgery patient. Plast Reconstr Surg. 2004;114:43E–51E.
   Google Scholar
• Kraft CT, Bellile E, Baker SR, et al. Anticoagulant complications in facial plastic and reconstructive surgery. JAMA Facial Plast Surg. 2015;17:103–107.
   Google Scholar
• Lassen MR, Ageno W, Borris LC, et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty. N Engl J Med. 2008;358:2776–2786.
   Google Scholar
• Turpie AG, Lassen MR, Davidson BL, et al. Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial. Lancet. 2009;373:1673–1680.
   Google Scholar
• FDA Approves XARELTO® (rivaroxaban tablets) to Help Prevent Deep Vein Thrombosis in Patients Undergoing Knee or Hip Replacement Surgery [press release]. 2011.
   Google Scholar
• Falck-Ytter Y, Francis CW, Johanson NA, et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e278S–e325S.
   Google Scholar
• Dini GM, Ferreira MC, Albuquerque LG, et al. How safe is thromboprophylaxis in abdominoplasty? Plast Reconstr Surg. 2012;130:851e–857e.
   Google Scholar
• Pannucci CJ, Cuker A. Commentary on: rivaroxaban for venous thromboembolism prophylaxis in abdominoplasty: a multicenter experience. Aesthet Surg J. 2016;36:67–70.
   Google Scholar
• Hunstad JP, Krochmal DJ, Flugstad NA, et al. Rivaroxaban for venous thromboembolism prophylaxis in abdominoplasty: a multicenter experience. Aesthet Surg J. 2016;36:60–66.
   Google Scholar
• Lassen MR, Gallus A, Raskob GE, et al. Apixaban versus enoxaparin for thromboprophylaxis after hip replacement. N Engl J Med. 2010;363:2487–2498.
   Google Scholar
• Lassen MR, Raskob GE, Gallus A, et al. Apixaban versus enoxaparin for thromboprophylaxis after knee replacement (ADVANCE-2): a randomised double-blind trial. Lancet. 2010;375:807–815.
   Google Scholar
• Weitz JI, Eikelboom JW, Samama MM. American College of Chest P. New antithrombotic drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e120S–e151S.
   Google Scholar
• Morales R, Jr., Ruff E, Patronella C, et al. Safety and efficacy of novel oral anticoagulants vs low molecular weight heparin for thromboprophylaxis in large-volume liposuction and body contouring procedures. Aesthet Surg J. 2016;36:440–449.
   Google Scholar
• Davison SP, Massoumi W. Our complication, your problem. Plast Reconstr Surg. 2007;120:1428–1429.
   Google Scholar
• Siegal DM, Curnutte JT, Connolly SJ, et al. Andexanet Alfa for the reversal of factor Xa inhibitor activity. N Engl J Med. 2015;373:2413–2424.
   Google Scholar
• Wes AM, Wink JD, Kovach SJ, et al. Venous thromboembolism in body contouring: an analysis of 17,774 patients from the National Surgical Quality Improvement databases. Plast Reconstr Surg. 2015;135:972e–980e.
   Google Scholar
• Santos DQ, Tan M, Farias CL, et al. Venous thromboembolism after facelift surgery under local anesthesia: results of a multicenter survey. Aesth Plast Surg.. 2014;38:12–24.
   Google Scholar
• Chen CM, Disa JJ, Cordeiro PG, et al. The incidence of venous thromboembolism after oncologic head and neck reconstruction. Ann Plast Surg. 2008;60:476–479.
   Google Scholar
• Andtbacka RH, Babiera G, Singletary SE, et al. Incidence and prevention of venous thromboembolism in patients undergoing breast cancer surgery and treated according to clinical pathways. Ann Surg. 2006;243:96–101.
   Google Scholar
• Lemaine V, McCarthy C, Kaplan K, et al. Venous thromboembolism following microsurgical breast reconstruction: an objective analysis in 225 consecutive patients using low-molecular-weight heparin prophylaxis. Plast Reconstr Surg. 2011;127:1399–1406.
   Google Scholar
• Nwaogu I, Yan Y, Margenthaler JA, et al. Venous thromboembolism after breast reconstruction in patients undergoing breast surgery: an American College of Surgeons NSQIP analysis. J Am Coll Surg. 2015;220:886–893.
   Google Scholar
• Keith JN, Chong TW, Davar D, et al. The timing of preoperative prophylactic low-molecular-weight heparin administration in breast reconstruction . Plast Reconstr Surg. 2013;132:279–284.
   Google Scholar
• Kaoutzanis C, Gupta V, Winocour J, et al. Cosmetic liposuction: preoperative risk factors, major complication rates, and safety of combined procedures. Aesthet Surg J. 2017;37:680–694.
   Google Scholar